Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3

doi:10.1002/pro.50

Article

You have full text access to this OnlineOpen article

Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3

Lei Jin^1,*,
Heidi Galonek¹,
Kristine Israelian¹,
Wendy Choy¹,
Michael Morrison¹,
Yu Xia^2,†,
Xiaohong Wang^2,†,
Yihua Xu^2,†,
Yuecheng Yang^2,†,
Jesse J. Smith¹,
Ethan Hoffmann¹,
David P. Carney¹,
Robert B. Perni¹,
Michael R. Jirousek¹,
Jean E. Bemis¹,
Jill C. Milne¹,
David A. Sinclair¹,
Christoph H. Westphal¹

Article first published online: 6 JAN 2009

DOI: 10.1002/pro.50

Issue

Protein Science

Volume 18, Issue 3, pages 514–525, March 2009

Additional Information

How to Cite

Jin, L., Galonek, H., Israelian, K., Choy, W., Morrison, M., Xia, Y., Wang, X., Xu, Y., Yang, Y., Smith, J. J., Hoffmann, E., Carney, D. P., Perni, R. B., Jirousek, M. R., Bemis, J. E., Milne, J. C., Sinclair, D. A. and Westphal, C. H. (2009), Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3. Protein Science, 18: 514–525. doi: 10.1002/pro.50

Author Information

¹
Sirtris, a GSK Company, 200 Technology Square, Cambridge, MA 02139
²
Shanghai Medicilon Inc., 67 Libing Road, Building 5, Zhangjiang High-Tech Park, Shanghai 201203, China

^†
Viva Biotech Ltd, 1043 Halei Road, Suite 502, Zhangjiang High-Tech Park, Shanghai 201203, China

Email: Lei Jin (ljin@sirtrispharma.com)

^*Sirtris, a GSK Company, 200 Technology Square, Cambridge, MA 02139

Publication History

Issue published online: 23 FEB 2009
Article first published online: 6 JAN 2009
Accepted manuscript online: 6 JAN 2009 12:00AM EST
Manuscript Accepted: 8 DEC 2008
Manuscript Revised: 5 DEC 2008
Manuscript Received: 8 SEP 2008

ARTICLE TOOLS

View Full Article (HTML) Get PDF (793K)

References

1
Dutnall RN, Pillus L ( 2001) Deciphering NAD-dependent deacetylases. Cell 105: 161–164.
2
Rusche LN, Kirchmaier AL, Rine J ( 2003) The establishment, inheritance, and function of silenced chromatin in Saccharomyces cerevisiae. Annu Rev Biochem 72: 481–516.
3
Straight AF, Shou W, Dowd GJ, Turck CW, Deshaies RJ, Johnson AD, Moazed D ( 1999) Net1, a Sir2-associated nucleolar protein required for rDNA silencing and nucleolar integrity. Cell 97: 245–256.
4
Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA ( 2003) Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol 23: 3173–3185.
5
Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P ( 2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434: 113–118.
6
Hallows WC, Lee S, Denu JM ( 2006) Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA 103: 10230–10235.
7
Li X, Zhang S, Blander G, Tse JG, Krieger M, Guarente L ( 2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28: 91–106.
8
Schwer B, Verdin E ( 2008) Conserved metabolic regulatory functions of sirtuins. Cell Metab 7: 104–112.
9
Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W ( 2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137–148.
10
Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA ( 2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149–159.
11
Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T ( 2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21: 2383–2396.
12
Blander G, Guarente L ( 2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417–435.
13
Haigis MC, Guarente LP ( 2006) Mammalian sirtuins–emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913–2921.
14
North BJ, Verdin E ( 2004) Sirtuins: Sir2-related NAD-dependent protein deacetylases. Genome Biol 5: 224.
15
North BJ, Marshall BL, Borra MT, Denu JM, Verdin E ( 2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11: 437–444.
16
Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I ( 2005) Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 16: 4623–4635.
17
Moynihan KA, Grimm AA, Plueger MM, Bernal-Mizrachi E, Ford E, Cras-Meneur C, Permutt MA, Imai S ( 2005) Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab 2: 105–117.
18
Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A, et al ( 2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 4: e31.
19
Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al ( 2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712–716.
20
Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I ( 2008) SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 861–870.
21
Saunders LR, Verdin E ( 2007) Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26: 5489–5504.
22
Vaitiekunaite R, Butkiewicz D, Krzesniak M, Przybylek M, Gryc A, Snietura M, Benedyk M, Harris CC, Rusin M ( 2007) Expression and localization of Werner syndrome protein is modulated by SIRT1 and PML. Mech Ageing Dev 128: 650–661.
23
Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, et al ( 2008) The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS ONE 3: e2020.
24
Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, et al ( 2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281: 21745–21754.
25
Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, et al ( 2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26: 3169–3179.
26
Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, et al ( 2007) Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol 27: 8807–8814.
27
Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E ( 2006) Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA 103: 10224–10229.
28
Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, et al ( 2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126: 941–954.
29
Allison SJ, Milner J ( 2007) SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle 6: 2669–2677.
30
Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A, et al ( 2007) Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130: 1095–1107.
31
Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V, Passarino G, Feraco E, Mari V, Barbi C, et al ( 2003) Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp Gerontol 38: 1065–1070.
32
Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, et al ( 2005) A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85: 258–263.
33
Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP ( 2002) SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci USA 99: 13653–13658.
34
Schwer B, North BJ, Frye RA, Ott M, Verdin E ( 2002) The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol 158: 647–657.
35
Cooper HM, Spelbrink JN ( 2008) The human Sirt3 protein deacetylase is exclusively mitochondrial. Biochem J 411: 279–285.
36
Scher MB, Vaquero A, Reinberg D ( 2007) SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21: 920–928.
37
Yang YH, Chen YH, Zhang CY, Nimmakayalu MA, Ward DC, Weissman S ( 2000) Cloning and characterization of two mouse genes with homology to the yeast Sir2 gene. Genomics 69: 355–369.
38
Shi T, Wang F, Stieren E, Tong Q ( 2005) SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 280: 13560–13567.
39
Hiller M, Platzer M ( 2008) Widespread and subtle: alternative splicing at short-distance tandem sites. Trends Genet 24: 246–255.
40
Notredame C, Higgins DG, Heringa J ( 2000) T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205–217.
41
Claros MG, Vincens P ( 1996) Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur J Biochem 241: 779–786.
Direct Link:
42
Small I, Peeters N, Legeai F, Lurin C ( 2004) Predotar: a tool for rapidly screening proteomes for N-terminal targeting sequences. Proteomics 4: 1581–1590.
Direct Link:
43
Emanuelsson O, Brunak S, von Heijne G, Nielsen H ( 2007) Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2: 953–971.
44
Landry J, Slama JT, Sternglanz R ( 2000) Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun 278: 685–690.
45
Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA ( 2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J Biol Chem 277: 45099–45107.
46
Sauve AA, Schramm VL ( 2003) Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. Biochemistry 42: 9249–9256.
47
Jackson MD, Schmidt MT, Oppenheimer NJ, Denu JM ( 2003) Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J Biol Chem 278: 50985–50998.
48
Borra MT, Langer MR, Slama JT, Denu JM ( 2004) Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases. Biochemistry 43: 9877–9887.
49
Copeland RA ( 2000) Enzymes, 2nd ed. New York: Wiley-VCH, Inc.
- CrossRef

View Full Article (HTML) Get PDF (793K)

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3

Protein Science

How to Cite

Author Information

Publication History

ARTICLE TOOLS

References

More content like this

JOURNAL TOOLS

JOURNAL MENU

FIND ISSUES

FIND ARTICLES

GET ACCESS

FOR CONTRIBUTORS

ABOUT THIS JOURNAL

SPECIAL FEATURES

Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3

Protein Science

How to Cite

Author Information

Publication History

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

References

More content like this